Back to Bills
HOUSE-BILL 5256119th Congress

HOUSE-BILL 5256: H.R.5256 - 340B ACCESS Act

Introduced: September 10, 2025
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 5256 aims to enhance access to affordable medications and healthcare services, particularly targeting low-income and uninsured individuals. The legislation emphasizes the importance of affordability and equitable access, invoking constitutional considerations related to healthcare rights and equal protection under the law. Key provisions include the establishment of sliding fee scales for low-income patients, ensuring maximum out-of-pocket costs for covered outpatient drugs, and mandating transparency and reporting requirements for covered entities and contract pharmacies. Additionally, the bill introduces civil monetary penalties for non-compliance, which serve to deter entities from failing to provide the necessary assistance. Implementation will require covered entities to adapt their practices to align with these new requirements, promoting accountability and protecting individuals' rights to affordable healthcare. Overall, the bill seeks to address significant disparities in healthcare access, potentially reshaping the landscape of prescription drug affordability and healthcare services for vulnerable populations.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant implications for individual rights, particularly in promoting access to healthcare for economically disadvantaged groups. By mandating affordability measures and transparency in drug pricing, it seeks to ensure that low-income individuals are not denied necessary medications due to financial constraints.

Key Individual Rights Affected

  • Right to access healthcare
  • Equal protection under the law

Constitutional Provisions

  • 14th Amendment - Equal Protection Clause
  • Due Process Clause

Potential Constitutional Challenges Or Support

Challenges

  • Concerns about federal overreach in regulating healthcare providers
  • Potential burdens on healthcare entities that could limit service availability

Support

  • Promotion of public health and welfare
  • Enhancement of equal treatment for low-income populations

Summary

HOUSE-BILL 5256 aims to improve access to affordable medications for low-income individuals, thereby supporting constitutional principles of equal protection and public health. While it may impose certain regulatory burdens on healthcare providers, its overall intent aligns with enhancing individual rights and access to necessary healthcare services.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 5256 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

September 10, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat